Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
05/08/2013 | CN103097389A 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace) |
05/08/2013 | CN103097388A New aminopyrazoloquinazolines |
05/08/2013 | CN103097387A Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases |
05/08/2013 | CN103097384A Substituted imidazo[1,2-a]pyrimidines and pyridines |
05/08/2013 | CN103087704A Sulfonic phenyl porphyrin zinc fluorescent material |
05/08/2013 | CN103087069A Synthesis method of 3,7-binitro-1,3,5,7-tetraazabicyclo[3.3.1]nonane |
05/08/2013 | CN103087068A Condensed-cyclic Compound And Organic Light-emitting Device Including The Same |
05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
05/08/2013 | CN103086986A Preparation method and application of 1,4-benzodiazepine-N-nitrosamine intermediate |
05/08/2013 | CN103086971A Nitrogenous heterocyclic derivative, preparation method thereof and application thereof in preparation of histone deacetylase I inhibitor |
05/08/2013 | CN103086912A Method for preparing pemetrexed and pemetrexed intermediate |
05/08/2013 | CN102334017B Method for proving authenticity using naphthalocyanine compound, signal transduction method, polymer welding method, method for producing lithographic printing plate, printing ink, toner, heat-shielding material, and method for producing naphthalocya |
05/08/2013 | CN102259027B Method for preparing cobalt phthalocyanine sulfonamide desulfurization catalyst |
05/08/2013 | CN102250100B Indolactam alkaloid and use of indolactam alkaloid in preparation of antimalarial drugs |
05/08/2013 | CN101778851B 稠合的双环嘧啶 Fused bicyclic pyrimidine |
05/07/2013 | USRE44205 Adenosine A2a receptor antagonists |
05/07/2013 | US8436242 Photocharge separation using supramolecular complex of π-electron type extended viologen derivative and porphyrin |
05/07/2013 | US8436004 Bicycloaniline derivative |
05/07/2013 | US8436003 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines |
05/07/2013 | US8435987 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
05/07/2013 | CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
05/02/2013 | WO2013063549A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
05/02/2013 | WO2013063468A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
05/02/2013 | WO2013063417A1 Methyltransferase inhibitors for treating cancer |
05/02/2013 | WO2013063368A1 Fullerene separation through use of organic cages |
05/02/2013 | WO2013062670A2 New routes to trans a,b-substituted bacteriochlorins |
05/02/2013 | WO2013062075A1 Organic electroluminescence element, and material for organic electroluminescence element |
05/02/2013 | WO2013062074A1 Imidazolone derivative |
05/02/2013 | WO2013062071A1 Piperazine derivative and salt thereof |
05/02/2013 | WO2013060980A1 Nucleoside analogues for treating a viral infection, and method for evaluating the sensitivity to said treatment |
05/02/2013 | WO2013060837A1 Synthesis of triazolopyrimidine compounds |
05/02/2013 | WO2013060818A1 Novel process |
05/02/2013 | WO2013060029A1 Allosteric modulators of metabotropic glutamate receptors |
05/02/2013 | WO2013059928A1 Hiv protease inhibitors |
05/02/2013 | WO2013028832A3 Inhibitors of nedd8-activating enzyme |
05/02/2013 | US20130109702 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
05/02/2013 | US20130109694 Compounds with antibacterial activity against clostridium |
05/02/2013 | US20130109685 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
05/02/2013 | US20130109679 Heterocyclic compounds containing an indole core |
05/02/2013 | US20130109673 Processes for making zilpaterol and salts thereof |
05/02/2013 | US20130109668 Azetidine compounds, compositions and methods of use |
05/02/2013 | US20130109661 Imidazopyridazine compounds |
05/02/2013 | US20130108573 Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
05/02/2013 | US20130105785 Novel organic compound and organic light-emitting device including the same |
05/02/2013 | US20130105769 Condensed-cyclic compound and organic light-emitting device including the same |
05/02/2013 | CA2853522A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
05/02/2013 | CA2853501A1 Methyltransferase inhibitors for treating cancer |
05/02/2013 | CA2852652A1 Synthesis of triazolopyrimidine compounds |
05/02/2013 | CA2849969A1 Nucleoside analogues for treating a viral infection, and method for evaluating the sensitivity to said treatment |
05/01/2013 | EP2586782A1 Crystalline salts of sitagliptin |
05/01/2013 | EP2586781A1 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
05/01/2013 | EP2586778A2 Pyridazinone derivatives useful as glucan synthase inhibitors |
05/01/2013 | EP2586773A1 Synthesis of Triazolopyrimidine Compounds |
05/01/2013 | EP2586441A1 Combination of egcg or methylated egcg and a pde inhibitor |
05/01/2013 | EP2585468A1 Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase |
05/01/2013 | EP2585467A1 Pyrazolo [1, 5 -a]pyrimidines as antiviral agents |
05/01/2013 | EP2585466A1 Polymorphs of osi-906 |
05/01/2013 | EP2585465A1 Benzotriazolodiazepine compounds inhibitors of bromodomains |
05/01/2013 | EP2585462A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
05/01/2013 | EP2585446A1 Compounds having trpv1 antagonistic activity and uses thereof |
05/01/2013 | EP2585438A1 PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2-{2-[METHYL-(SULPHAMOYL)-AMINO]-ETHOXY}-ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID |
05/01/2013 | EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor |
05/01/2013 | CN103080113A 7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals |
05/01/2013 | CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders |
05/01/2013 | CN103079571A Noribogaine compositions |
05/01/2013 | CN103073553A Water-soluble naphthalocyanine base compound, preparation method and application of compound as photosensitizer |
05/01/2013 | CN103073552A Preparation method for amorphous tofacitinib citrate |
05/01/2013 | CN103073551A Separation technology for cyclic dipeptide C2 in phellinus igniarius |
05/01/2013 | CN103073550A Separation technology for cyclic dipeptide C4 in phellinus igniarius |
05/01/2013 | CN103073549A 3-bromopyrazol[1,5-alpha]pyrimidine-2-formic acid synthesis process |
05/01/2013 | CN102775412B Sedative and soporific compound, and preparation method and application thereof |
05/01/2013 | CN102180879B Polycrystalline type alpha acetic acid solvate of hypnotic |
05/01/2013 | CN102017218B Organic electroluminescent element |
05/01/2013 | CN102015711B Spiro-indole derivatives for the treatment of parasitic diseases |
05/01/2013 | CN101820881B Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treament of inflammation |
05/01/2013 | CN101657430B Organic compounds and their uses |
05/01/2013 | CN101448831B Imidazo [1, 2-b] pyridazines, their processes of preparation and their use as GABA receptor ligands |
05/01/2013 | CN101341134B 嘧啶衍生物 Pyrimidine derivatives |
05/01/2013 | CN101056852B Iodine-phenyl-substituted cyclic cetoenols |
04/30/2013 | US8431695 Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
04/30/2013 | US8431584 Heterobicyclic carboxamides as inhibitors for kinases |
04/30/2013 | US8431581 Imidazopyrimidines and uses thereof |
04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
04/30/2013 | US8431573 Cyanopyrimidinones |
04/30/2013 | US8431569 Inhibitors of janus kinases |
04/30/2013 | US8431568 Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors |
04/30/2013 | US8431565 Substituted imidazoheterocycles |
04/30/2013 | CA2692761C Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation |
04/30/2013 | CA2673249C 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
04/30/2013 | CA2584567C Pyrazolo (1,5-alpha) pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
04/30/2013 | CA2571487C Pyrrazolo-pyrimidine derivatives |
04/25/2013 | WO2013059594A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
04/25/2013 | WO2013059589A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
04/25/2013 | WO2013059265A1 A compound for the treatment of hepatitis c |
04/25/2013 | WO2013057944A1 Novel spiroindoline compound, and medicinal agent comprising same |
04/25/2013 | WO2013057711A1 Quinazoline derivatives as pi3k modulators |
04/25/2013 | WO2013057650A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators |
04/25/2013 | WO2013057205A1 Diazabicyclo- and diazaspiro-alkane derivatives as phosphodiesterase-5 inhibitors |
04/25/2013 | WO2013057123A1 Process for the preparation of isoxazolyl-methoxy-nicotinic acids |
04/25/2013 | WO2012174487A3 Bromodomain inhibitors and uses thereof |